BNOS 2022 | Genetics as a risk factor and a biomarker in glioma

Lily Andrews, University of Bristol, Bristol, UK, talks on genetics as a risk factor for glioma as well as a potential biomarker. Whilst various potential biomarkers have been discovered, more research is required to investigate the proteomics of glioma. This interview took place at the British Neuro-Oncology Society (BNOS) Annual Meeting 2022.